Loading…
Spectral AI, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in MDAI.
▼ -83.6% over 5Y.
today you would have $163.75▼ -83.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 5 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $1.42 | $2.83 | $2.46 | $10.10 | $9.81 | |
| P/S | 2.4x | 2.3x | 2.4x | 2.4x | 5.2x | — |
| P/B | — | — | — | — | 11.1x | — |
| EPS | -$0.29 | -$0.85 | -$1.48 | -$0.22 | — |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MREOMereo BioPharma Group plc | $0.32 | — | 1.8x | — | -67.85% | $50.51M |
| TCRXTScan Therapeutics, Inc. | $0.75 | — | 0.5x | — | -95.81% | $51.07M |
| TILInstil Bio, Inc. | $7.58 | — | 0.5x | — | -25.33% | $51.41M |
| PRPOPrecipio, Inc. | $28.85 |
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.
Company description provided by Yahoo Finance.
| Profit margin | -44.89% | -38.53% | -51.24% | -115.50% | -11.48% | — |
| ROE | — | — | — | — | -24.27% | -15.62% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 3.5x |
| — |
| -8.98% |
| $51.65M |
| NEPHNephros Inc | $4.55 | 28.4x | 4.1x | — | 16.10% | $49.41M |
| ELOXEloxx Pharmaceuticals, Inc. | $15.07 | 4.7x | 1.3x | — | — | $51.79M |